Boothbay Fund Management, LLC Novavax Inc Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.81 - $9.74 $478,743 - $684,722
70,300 Added 86.47%
151,600 $1.1 Million
Q2 2023

Aug 14, 2023
BUY
$6.67 - $9.52 $542,271 - $773,976
81,300 New
81,300 $604,000
Q4 2021

Feb 14, 2022
SELL
$134.56 - $217.97 $955,376 - $1.55 Million
-7,100 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$177.8 - $270.58 $1.26 Million - $1.92 Million
7,100 New
7,100 $1.47 Million

Others Institutions Holding NVAX

# of Institutions
291
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $674M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email